Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8AJJ

Crystal structure of the disulfide reductase MerA from Staphylococcus aureus

Summary for 8AJJ
Entry DOI10.2210/pdb8ajj/pdb
DescriptorDihydrolipoamide dehydrogenase, FLAVIN-ADENINE DINUCLEOTIDE, HISTIDINE, ... (4 entities in total)
Functional Keywordsmera, disulfide reductase, oxidoreductase
Biological sourceStaphylococcus aureus
Total number of polymer chains4
Total formula weight200590.92
Authors
Weiland, P.,Altegoer, F.,Bange, G. (deposition date: 2022-07-28, release date: 2023-03-01, Last modification date: 2024-10-23)
Primary citationShearer, H.L.,Loi, V.V.,Weiland, P.,Bange, G.,Altegoer, F.,Hampton, M.B.,Antelmann, H.,Dickerhof, N.
MerA functions as a hypothiocyanous acid reductase and defense mechanism in Staphylococcus aureus.
Mol.Microbiol., 119:456-470, 2023
Cited by
PubMed Abstract: The major pathogen Staphylococcus aureus has to cope with host-derived oxidative stress to cause infections in humans. Here, we report that S. aureus tolerates high concentrations of hypothiocyanous acid (HOSCN), a key antimicrobial oxidant produced in the respiratory tract. We discovered that the flavoprotein disulfide reductase (FDR) MerA protects S. aureus from this oxidant by functioning as a HOSCN reductase, with its deletion sensitizing bacteria to HOSCN. Crystal structures of homodimeric MerA (2.4 Å) with a Cys -Cys intramolecular disulfide, and reduced MerACys S (1.6 Å) showed the FAD cofactor close to the active site, supporting that MerA functions as a group I FDR. MerA is controlled by the redox-sensitive repressor HypR, which we show to be oxidized to intermolecular disulfides under HOSCN stress, resulting in its inactivation and derepression of merA transcription to promote HOSCN tolerance. Our study highlights the HOSCN tolerance of S. aureus and characterizes the structure and function of MerA as a major HOSCN defense mechanism. Crippling the capacity to respond to HOSCN may be a novel strategy for treating S. aureus infections.
PubMed: 36779383
DOI: 10.1111/mmi.15035
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon